Literature DB >> 1389529

Screening for psychiatric disorders in a lymphoma out-patient population.

D Razavi1, N Delvaux, A Bredart, M Paesmans, L Debusscher, D Bron, P Stryckmans.   

Abstract

The Hospital Anxiety and Depression Scale (HADS), a four-point, 14-item self-assessment questionnaire, was tested as a screening method for psychiatric disorders in a sample of 117 Hodgkin's lymphoma and non-Hodgkin lymphoma consecutive out-patients. A receiver operating characteristic (ROC) analysis was performed, giving the relationship between the true positive rate (sensitivity) and the false positive rate (1--specificity). This makes it possible to choose an optimal cut-off score that takes into account the costs and benefits of treatment of psychiatric disorders (mainly adjustment, depressive and anxiety disorders) in a lymphoma out-patient population. A cut-off point of 10 gave 84% sensitivity and 66% specificity. HADS appears in this study to be a well accepted, simple, sensitive and specific tool.

Entities:  

Mesh:

Year:  1992        PMID: 1389529     DOI: 10.1016/0959-8049(92)90025-w

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  17 in total

1.  Screening for mental disorders in cancer, cardiovascular and musculoskeletal diseases. Comparison of HADS and GHQ-12.

Authors:  Martin Härter; Sonja Woll; Alexandra Wunsch; Jürgen Bengel; Katrin Reuter
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2006-01-01       Impact factor: 4.328

2.  Influence of the pathological psychological state of cancer patients on their decisions.

Authors:  A Riskó; T Fleischmann; Z Molnár; T Schneider; E Várady
Journal:  Support Care Cancer       Date:  1996-01       Impact factor: 3.603

Review 3.  Common psychiatric disorders in cancer patients. I. Adjustment disorders and depressive disorders.

Authors:  D Razavi; F Stiefel
Journal:  Support Care Cancer       Date:  1994-07       Impact factor: 3.603

4.  Professional rehabilitation of lymphoma patients: a study of psychosocial factors associated with return to work.

Authors:  D Razavi; N Delvaux; A Brédart; P Autier; D Bron; L Debusscher; P Stryckmans
Journal:  Support Care Cancer       Date:  1993-09       Impact factor: 3.603

5.  Determinants of health-related quality of life in long-term survivors of Hodgkin's lymphoma.

Authors:  L Wettergren; M Björkholm; U Axdorph; A Langius-Eklöf
Journal:  Qual Life Res       Date:  2004-10       Impact factor: 4.147

6.  Screening Tools for Anxiety in People with Multiple Sclerosis: A Systematic Review.

Authors:  Brittany Litster; Kirsten M Fiest; Scott B Patten; John D Fisk; John R Walker; Lesley A Graff; James M Bolton; Jitender Sareen; James J Marriott; Lindsay I Berrigan; Charles N Bernstein; Ryan Zarychanski; Alexander Singer; Carol A Hitchon; Christine A Peschken; Ruth Ann Marrie
Journal:  Int J MS Care       Date:  2016 Nov-Dec

Review 7.  Accuracy of the Hospital Anxiety and Depression Scale as a screening tool in cancer patients: a systematic review and meta-analysis.

Authors:  Andrea Vodermaier; Roanne D Millman
Journal:  Support Care Cancer       Date:  2011-09-04       Impact factor: 3.603

8.  The value of the Hospital Anxiety and Depression Scale (HADS) for comparing women with early onset breast cancer with population-based reference women.

Authors:  R H Osborne; G R Elsworth; M A G Sprangers; F J Oort; J L Hopper
Journal:  Qual Life Res       Date:  2004-02       Impact factor: 4.147

9.  Impact of secondary lymphedema after head and neck cancer treatment on symptoms, functional status, and quality of life.

Authors:  Jie Deng; Barbara A Murphy; Mary S Dietrich; Nancy Wells; Kenneth A Wallston; Robert J Sinard; Anthony J Cmelak; Jill Gilbert; Sheila H Ridner
Journal:  Head Neck       Date:  2012-07-12       Impact factor: 3.147

10.  The psychosocial evaluation of medically-ill inpatients - accordance between mental disorders and self-rated psychosocial distress.

Authors:  Kurt Fritzsche; Thorsten Burger; Armin Hartmann; Matthias Nübling; Claudia Spahn
Journal:  Psychosoc Med       Date:  2005-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.